Tag: Cancer: Prostate
Prognosis Good With Negative Biopsy in Active Surveillance
Negative biopsies during active surveillance for low-risk prostate cancer tied to more favorable outcomes
Cardiorespiratory Fitness Reduced With Prolonged ADT in Prostate Cancer
Increased cardiovascular mortality also seen with prolonged androgen deprivation therapy for prostate cancer
Biopsy Reclassification Risk in Prostate Cancer Examined
Gleason grade, prostate-specific antigen velocity, and imaging markers predict cancer spread
Higher Health Literacy Linked to Odds of PSA Screening
However, patients with higher health literacy less likely to undergo PSA screening in the presence of shared decision-making
Some Outcomes Worse for Black Men With Low-Risk Prostate Cancer
Ten-year cumulative incidence of disease progression, receipt of definitive treatment increased
U.S. Incidence of Distant-Stage Prostate Cancer Up, 2010 to 2017
Five-year survival for distant-stage prostate cancer improved from 2011 to 2016
BMD Testing Rates Low in Men Initiating ADT for Prostate Cancer
Odds of BMD testing up with history of osteoporosis, rheumatoid arthritis, bisphosphonate use
Adjuvant Radiotherapy No Better for Localized Prostate Cancer
Event-free survival not improved with use of adjuvant versus early salvage radiotherapy
Ultrasound Ablation Offers Option for Some With Prostate Cancer
Bilateral prostate cancer at diagnosis was sole predictor of Grade Group 2 or greater recurrence
Darolutamide Boosts Survival in Nonmetastatic Prostate Cancer
Risk for death significantly lower versus placebo in nonmetastatic, castration-resistant prostate cancer
